Drug Metabolism and Personalized Therapy
SJR0.322
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.322 | Q2 | 46.0% | |
| 2024 | — | — | 0.271 | Q2 | 42.3% | |
| 2023 | — | — | 0.267 | Q2 | 45.2% | |
| 2022 | — | — | 0.301 | Q2 | 50.8% | |
| 2021 | — | — | 0.311 | Q2 | 52.5% | |
| 2020 | — | — | 0.346 | Q2 | 55.0% | |
| 2019 | — | — | 0.282 | Q2 | 50.4% | |
| 2018 | — | — | 0.277 | Q2 | 47.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2363-8915
ISSN
2363-8907
region
Western Europe
coverage
2015-2026